JP2025508473A - 両性イオン性抗菌化合物 - Google Patents

両性イオン性抗菌化合物 Download PDF

Info

Publication number
JP2025508473A
JP2025508473A JP2024550248A JP2024550248A JP2025508473A JP 2025508473 A JP2025508473 A JP 2025508473A JP 2024550248 A JP2024550248 A JP 2024550248A JP 2024550248 A JP2024550248 A JP 2024550248A JP 2025508473 A JP2025508473 A JP 2025508473A
Authority
JP
Japan
Prior art keywords
carbonyl
amino
methyl
pyrazol
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024550248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508473A5 (https=
Inventor
ブラン,ジャン-バティスト・エマニュエル
ラーナー,クリスティアン
マッテイ,パトリツィオ
ポヴァー,ジェイコブ・ウィリアム
シュミット,ゼーバスティアン
シュトル,テオドール・ヴァルター・ヤコプ
ウルセマー,サンドラ・マリー・ジョゼフ
ウルナー,ロレンツ・ミヒャエル
ヴィマー,シュテファン・ヘルマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2025508473A publication Critical patent/JP2025508473A/ja
Publication of JP2025508473A5 publication Critical patent/JP2025508473A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2024550248A 2022-02-25 2023-02-23 両性イオン性抗菌化合物 Pending JP2025508473A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158739.7 2022-02-25
EP22158739 2022-02-25
PCT/EP2023/054499 WO2023161316A1 (en) 2022-02-25 2023-02-23 Zwitterionic antibacterial compounds

Publications (2)

Publication Number Publication Date
JP2025508473A true JP2025508473A (ja) 2025-03-26
JP2025508473A5 JP2025508473A5 (https=) 2026-03-03

Family

ID=80461664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024550248A Pending JP2025508473A (ja) 2022-02-25 2023-02-23 両性イオン性抗菌化合物

Country Status (7)

Country Link
US (1) US20250179066A1 (https=)
EP (1) EP4482583B1 (https=)
JP (1) JP2025508473A (https=)
CN (1) CN118632842A (https=)
AR (1) AR128612A1 (https=)
TW (1) TW202402748A (https=)
WO (1) WO2023161316A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016347456B2 (en) 2015-10-27 2018-12-13 F. Hoffmann-La Roche Ag Peptide macrocycles against acinetobacter baumannii
US11505573B2 (en) 2018-03-28 2022-11-22 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
US11819532B2 (en) 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
WO2020182648A1 (en) 2019-03-08 2020-09-17 F. Hoffmann-La Roche Ag Novel imidazole-pyrazole derivatives
CN114981259B (zh) * 2020-01-22 2024-06-18 豪夫迈·罗氏有限公司 新型杂环化合物

Also Published As

Publication number Publication date
WO2023161316A1 (en) 2023-08-31
CN118632842A (zh) 2024-09-10
TW202402748A (zh) 2024-01-16
AR128612A1 (es) 2024-05-29
US20250179066A1 (en) 2025-06-05
EP4482583A1 (en) 2025-01-01
EP4482583B1 (en) 2026-04-01

Similar Documents

Publication Publication Date Title
JP7715634B2 (ja) 新規イミダゾール-ピラゾール誘導体
JP2018519302A (ja) 抗菌化合物
EP4077324A1 (en) Novel compounds and their use
JP7715715B2 (ja) 新規複素環式化合物
JP7823030B2 (ja) 抗菌薬としてのイミダゾール-ピラゾール誘導体
CN117881679A (zh) 新型化合物及其应用
JP7815147B2 (ja) 新規イミダゾピラジン誘導体
JP7846093B2 (ja) 新規複素環式抗生物質
JP7830431B2 (ja) 抗菌特性を有するイミダゾール-ピラゾール誘導体
WO2023280733A1 (en) Quaternary ammonium cation substituted compounds for the treatment of bacterial infections
JP7824232B2 (ja) 新規イミダゾピラジン誘導体
JP7771084B2 (ja) 抗菌8-フェニルアミノ-3-(ピラゾール-4-イル)イミダゾ[1,2-a]ピラジン誘導体
JP2025508473A (ja) 両性イオン性抗菌化合物
HK40110645A (zh) 两性离子抗细菌化合物
CN116829546A (zh) 新型杂芳基取代的咪唑衍生物
JP2023529578A (ja) 新規イミダゾ-ピラジン誘導体
HK40079569A (en) Antibacterial 8-phenylamino-3-(pyrazol-4-yl)imidazo[1,2-a]pyrazine derivatives
WO2023066834A1 (en) Pyrrolidine derivatives as ddrs inhibitors
HK40087753A (zh) 新型咪唑并吡嗪衍生物
HK40013317B (zh) 作为janus激酶抑制剂的新的氨基-咪唑并吡啶衍生物及其医药用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260219